XBI

Bluebird Bio Stock Is in Free Fall

December 20, 2023 · Business

Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly 100,000 people in…

Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

January 13, 2023 · Business

Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime…